Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
Warner Bros. Discovery posts strong Q2 results, driven by studio successes and streaming growth, as it prepares to split into two entities.
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
Warner Bros. Discovery posts strong Q2 results, driven by studio successes and streaming growth, as it prepares to split into two entities.
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.